Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

ASCO membership empowers you to be part of a larger voice advocating on behalf of the oncology profession to ensure that the real challenges facing oncology practices are taken into consideration by policymakers. You can get involved with the ASCO ACT Network and stay up-to-date with ASCO in Action on emerging government policies, regulations, and legal issues that may impact the practice of oncology. Learn more about the value of ASCO membership and gain what you need.
Reimbursement cuts in certain oncology specialties. Consolidated payments for certain E&M services. Reduced reimbursement for new Medicare Part B drugs. These are some of the changes coming to the Medicare Physician Fee Schedule and the Quality Payment Program this year. In the latest ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis discusses these changes and what this may mean for your oncology practice.
As part of the Trump Administration’s continuing effort to address the cost of prescription drugs, CMS recently solicited input on a proposed new pilot program to test mechanisms for reducing drug costs. The International Pricing Index Model (IPI) for Medicare Part B drugs proposes sweeping reforms that would, in part, benchmark some Medicare Part B drug prices against other countries and change how providers get paid for administering drugs to patients.